Fluomizin

Fluomizin is an over‑the‑counter vaginal tablet that contains 10 mg of dequalinium chloride, a quaternary ammonium antiseptic. It is marketed in the European Union and classified as a vaginal antiseptic (ATC code D07AA02). The product is intended for local use in the vagina to address microbial imbalances and related symptoms such as discharge, itching, and irritation. It is available without a prescription and is formulated for short‑term use.

Fluomizin is indicated for the local treatment of common vaginal conditions that are associated with microbial overgrowth, providing antiseptic action to help restore a balanced vaginal environment.

- Management of bacterial vaginosis‑related symptoms. - Adjunctive therapy for trichomoniasis‑associated discharge. - Relief of non‑specific vaginal itching and irritation. - Reduction of abnormal vaginal discharge of uncertain origin. - Short‑term antiseptic support after gynecological procedures. - Support for women experiencing mild vaginal odor linked to bacterial imbalance. - Temporary relief during the early phase of antibiotic therapy for vaginal infections.

The safety profile of Fluomizin reflects the local action of dequalinium chloride; most adverse events are mild and limited to the application site. Because the active ingredient works by disrupting microbial cell membranes, systemic absorption is minimal, and side effects are generally confined to the vaginal mucosa.

Common: - Mild vaginal burning or stinging sensation. - Transient vaginal dryness. - Light spotting or spotting after insertion. - Temporary increase in vaginal discharge. - Mild itching or pruritus in the vaginal area. - Slight foul odor that resolves quickly.

Serious: - Allergic reaction with swelling, rash, or hives. - Severe irritation leading to ulceration or ulcer‑like lesions. - Persistent pain or severe inflammation requiring medical evaluation.

When using Fluomizin, certain precautions help minimize risks and ensure appropriate use. Patients should follow the product information and consider individual health factors before initiating therapy.

- Avoid use if you are allergic to dequalinium chloride or any tablet ingredients. - Do not exceed the recommended treatment period without consulting a clinician. - Do not insert the tablet when the vaginal tissue is severely inflamed, ulcerated, or actively bleeding. - Seek medical advice before use during pregnancy or breastfeeding, as safety information is limited. - Store at room temperature, keep the container closed, and keep out of reach of children.

Fluomizin may interact with other substances applied to the vagina; awareness of potential interactions helps maintain effectiveness and safety. Consider the following when using other intravaginal products or systemic medications.

Avoid: - Do not use other antiseptic or antimicrobial vaginal tablets, creams, or gels at the same time, as they may diminish Fluomizin’s effect. - Avoid spermicidal devices or lubricants with non‑ionic surfactants immediately before or after insertion.

Use with caution: - Use with caution if you are on topical estrogen, which can alter vaginal pH. - If taking systemic antibiotics, monitor the infection as additional therapy may be needed. - Concurrent antifungal agents may increase local irritation; consult a clinician.